WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical.
WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. As an innovation-driven and customer-focused company, WuXi AppTec helps our partners improve the productivity of advancing healthcare products through cost-effective and efficient solutions,With industry-leading capabilities such as R&D and manufacturing for small molecule drugs, cell and gene therapies, and testing for medical devices, WuXi AppTec's open-access platform is enabling more than 3,900 collaborators from over 30 countries to improve the health of those in need – and to realize our vision that "every drug can be made and every disease can be treated".
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Feb 1, 2005 | Series Unknown | $11M | 1 | — | — | Detail |
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Mar 2, 2020
Immunocore
|
Series B | $130M | Biotechnology | — |
Jan 4, 2019
Schrödinger
|
Series E | $107.82M | Biotechnology | Yes |
Jul 17, 2018
Verge Genomics
|
Series A | $32M | Biotechnology | — |
Feb 12, 2017
Forerunner Medical
|
Series B | — | Biotechnology | — |
Apr 22, 2015
DNAnexus
|
Series D | $15M | Bioinformatics | Yes |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Commerce Health Capital | — | Series Unknown |